SOPHARMA AD hereby informs that from 29 January 2015 up to and including 4 February 2015 the Company bought 3 200 own shares representing 0.0024% of the share capital of the Company, at a total value of 11 534.90 BGN on the Bulgarian Stock Exchange, the average price per share was 3.605 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 126 021, representing 3.88% of the share capital of the Company.

SOPHARMA AD hereby informs that from 18 December 2014 up to and including 7 January 2015 the Company bought 3897 own shares representing 0.003% of the share capital of the Company, to the total value of 15 019.98 BGN on the Bulgarian Stock Exchange, the average price per share was 3.85 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 117 450, representing 3.88% of the share capital of the Company.

Sopharma AD notifies that for December 2014 the Company recorded a decrease of sales revenues of 29% compared to the same month of 2013, including 20% decrease of domestic sales and 36% decrease of export sales.

During the past year Sopharma AD recorded a decrease of sales revenues of 7%, including 1% increase of domestic sales and 10% decrease of export sales compared to 2013.

We would hereby like to notify that the Extraordinary General Meeting of Shareholders of Sopharma AD held on January 9, 2015 in Sofia took a decision for trnasformation of Sopharma AD throught the merger of Bulgarian Rose – Sevtopolis AD based in the city of Kazanlak, UIC 123007916. As a result the whole property of Bulgarian Rose – Sevtopolis AD will be transferred to Sopharma AD with the full rights.

SOPHARMA AD hereby informs that from 8 January 2015 up to and including 14 January 2015 the Company bought 2 677 own shares representing 0.002% of the share capital of the Company, to the total value of 9 957.10 BGN on the Bulgarian Stock Exchange, the average price per share was 3.72 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 120 127, representing 3.88% of the share capital of the Company.

SOPHARMA AD hereby informs that from 15 January 2015 up to and including 21 January 2015 the Company bought 1 000 own shares representing 0.00076% of the share capital of the Company, to the total value of 3 720.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.72 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 121 127, representing 3.88% of the share capital of the Company.

SOPHARMA AD hereby informs that from 10 February 2015 up to and including 13 February 2015 the Company bought 10 500 own shares representing 0.0080% of the share capital of the Company, at a total value of 37 792 BGN on the Bulgarian Stock Exchange, the average price per share was 3.599 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 136 521, representing 3.89% of the share capital of the Company.

The volatility of the RUB caused us to undertake actions to adjust the prices for our main export market - Russia, which prevented us from exporting during the period. Our forecast is that this slow down in the beginning of the year will be compensated already in the first quarter.

SOPHARMA AD hereby informs that from 10 February 2015 up to and including 13 February 2015 the Company bought 10 500 own shares representing 0.0080% of the share capital of the Company, at a total value of 37 792 BGN on the Bulgarian Stock Exchange, the average price per share was 3.599 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 136 521, representing 3.89% of the share capital of the Company.

SOPHARMA AD hereby informs that from 12 February 2015 up to and including 18 February 2015 the Company bought 7 150 own shares representing 0.0054% of the share capital of the Company, at a total value of 25 608.50 BGN on the Bulgarian Stock Exchange, the average price per share was 3.58 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 143 671, representing 3.90% of the share capital of the Company.